True about Pralidoxime ?
**Core Concept**
Pralidoxime, also known as 2-PAM, is a medication used to treat organophosphate poisoning, which occurs when the body is exposed to toxic substances that inhibit acetylcholinesterase, an enzyme responsible for breaking down the neurotransmitter acetylcholine. Pralidoxime works by reactivating acetylcholinesterase, thereby reversing the toxic effects of organophosphate poisoning.
**Why the Correct Answer is Right**
Pralidoxime acts by covalently binding to the phosphorylated acetylcholinesterase enzyme, effectively removing the phosphate group and restoring the enzyme's ability to break down acetylcholine. This process is crucial in treating organophosphate poisoning, as it helps to alleviate muscle spasms, respiratory failure, and other systemic complications associated with acetylcholine accumulation. Pralidoxime's mechanism of action is distinct from atropine, which is also used to treat organophosphate poisoning, but works by blocking acetylcholine receptors.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because pralidoxime does not work by blocking acetylcholine receptors; that is the mechanism of action of atropine.
**Option B:** Incorrect because pralidoxime is not used to treat carbamate poisoning; oximes like pralidoxime are specific to organophosphate poisoning.
**Option C:** Incorrect because pralidoxime is not a cholinesterase inhibitor; it is an antidote that reactivates the enzyme.
**Clinical Pearl / High-Yield Fact**
It is essential to note that pralidoxime is most effective when administered within 24-48 hours of organophosphate exposure, and its efficacy decreases significantly if treatment is delayed beyond this timeframe.